The Centre for Drug Design and Discovery raises 70.5 Million Euros for its fourth fund

The Centre for Drug Design and Discovery (CD3), a pioneering organization specializing in translating innovative biomedical research into life-saving medicines, today announced the successful closure of CD3 IV, raising 70.5 million euros. This investment brings the total capital managed by CD3 to 154.5 million euros.
account creation

TO READ THIS ARTICLE, CREATE YOUR ACCOUNT

And extend your reading, free of charge and with no commitment.